The House panel responsible for federal appropriations legislation passed a bill last week that would cut funding for the Health [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
The rates 340B pediatric hospitals negotiate with payers for new pediatric oncology drugs often exceed a medication’s average sale price, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
As hospital advocates prepared to begin their annual summer visits to Capitol Hill this week, five congressional Democrats signed on [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: In Tuesday’s issue, we looked at comments from 340B provider stakeholders, today we look more closely at the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Canadian drug manufacturer recently announced that it will refund covered entities for hundreds of different products purchased between 2021 [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: In today’s issue, we look at the 340B provider community’s comments to CMS. In a future issue, we [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Japanese drug manufacturer has ended its 340B contract pharmacy restrictions in Maryland and Mississippi in conjunction with new contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drug manufacturers are suing Minnesota to block a new 340B contract pharmacy access law, which took effect this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drug manufacturers this week sued Kansas in an effort to block the state’s new contract pharmacy access law, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Groups representing Maryland providers along with national advocacy groups recently urged a federal judge to reject Novartis’ attempt to block [...] …
